Intuitive Surgical, Inc. Website

Intuitive Surgical, Inc.

NasdaqGS-ISRG

Basic

  • Market Cap

    $151.03B

  • EV

    $146.31B

  • Shares Out

    354.71M

  • Revenue

    $7,318.5M

  • Employees

    13,676

Margins

  • Gross

    66.43%

  • EBITDA

    30.98%

  • Operating

    25.26%

  • Pre-Tax

    28.36%

  • Net

    27.16%

  • FCF

    8.14%

Returns (5Yr Avg)

  • ROA

    12.56%

  • ROTA

    14.62%

  • ROE

    14.46%

  • ROCE

    14.6%

  • ROIC

    20%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $423.57

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $4,800.1M

  • Net Debt

    -$4,800.1M

  • Debt/Equity

    0.01

  • EBIT/Interest

Growth (CAGR)

  • Rev 3Yr

    17.16%

  • Rev 5Yr

    13.71%

  • Rev 10Yr

    13.31%

  • Dil EPS 3Yr

    19.58%

  • Dil EPS 5Yr

    11.57%

  • Dil EPS 10Yr

    14.11%

  • Rev Fwd 2Yr

    14.41%

  • EBITDA Fwd 2Yr

    14.5%

  • EPS Fwd 2Yr

    13.47%

  • EPS LT Growth Est

    14.07%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

4,478.5

4,358.4

5,710.1

6,222.2

7,124.1

7,318.5

Total Revenues % Chg.

20.3%

-2.7%

31%

9%

14.5%

13.8%

Cost of Goods Sold, Total

1,368.3

1,497.2

1,751.6

2,026.2

2,394.6

2,456.6

Gross Profit

3,110.2

2,861.2

3,958.5

4,196

4,729.5

4,861.9

Selling General & Admin Expenses, Total

1,178.4

1,216.3

1,466.5

1,711.8

1,963.9

1,974.9

R&D Expenses

557.3

595.1

671

879

998.8

1,038.4

Other Operating Expenses, Total

1,735.7

1,811.4

2,137.5

2,590.8

2,962.7

3,013.3

Operating Income

1,374.5

1,049.8

1,821

1,605.2

1,766.8

1,848.6

Interest And Investment Income

116.8

103.5

80.8

106

203.1

244.6

Net Interest Expenses

116.8

103.5

80.8

106

203.1

244.6

Currency Exchange Gains (Loss)

4.9

-1.4

-0.9

-27.3

-3.7

-6.9

EBT, Excl. Unusual Items

1,496.2

1,151.9

1,900.9

1,683.9

1,966.2

2,086.3

Gain (Loss) On Sale Of Investments

6

55.1

-10.6

-49

-7.3

-10.7

Legal Settlements

-28.1

EBT, Incl. Unusual Items

1,502.2

1,207

1,890.3

1,606.8

1,958.9

2,075.6

Income Tax Expense

120.4

140.2

162.2

262.4

141.6

71.7

Earnings From Continuing Operations

1,381.8

1,066.8

1,728.1

1,344.4

1,817.3

2,003.9

Minority Interest

-2.5

-6.2

-23.5

-22.1

-19.3

-16.3

Net Income

1,379.3

1,060.6

1,704.6

1,322.3

1,798

1,987.6

Net Income to Common Incl Extra Items

1,379.3

1,060.6

1,704.6

1,322.3

1,798

1,987.6

Net Income to Common Excl. Extra Items

1,379.3

1,060.6

1,704.6

1,322.3

1,798

1,987.6

Total Shares Outstanding

348

353.1

357.7

350

352.3

354.7

Weighted Avg. Shares Outstanding

346.2

351.1

356.1

355.7

351.2

352

Weighted Avg. Shares Outstanding Dil

358.4

361

365.8

362

357.4

358.5

EPS

4

3

4.8

3.7

5.1

5.6

EPS Diluted

3.9

2.9

4.7

3.7

5

5.5

EBITDA

1,574.5

1,320.6

2,128.4

1,959

2,169

2,267.4

Effective Tax Rate

8%

11.6%

8.6%

16.3%

7.2%

3.5%